Products found to contain undeclared medicines
|
| |
| Australia: Safety advisory: Artri King Tablets contain the undeclared substances diclofenac, dexamethasone and phenolphthalein |
| |
Therapeutic Goods Administration (TGA) announces that it has tested a product labelled Artri King tablets and found that the tablets contain the undeclared substances diclofenac, dexamethasone and phenolphthalein.
Diclofenac, dexamethasone and phenolphthalein taken either alone or in combination with other medication can cause serious side effects. Consumers are advised that dexamethasone, phenolphthalein and diclofenac (at certain higher dosages) are prescription-only medicines in Australia. The supply of Artri King tablets containing undisclosed diclofenac, dexamethasone and phenolphthalein is illegal. Artri King tablets have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/news/safety-alerts/artri-king-tablets
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by the FDA, and was posted on the Drug Office website on 22 Apr 2022 and 24 Oct 2023.
Ends/Wednesday, Jan 31, 2024
Issued at HKT 15:30
|
| |
|
